@article{Gorman_E-2023_137997,
title = {Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicentre, Randomised, Controlled Trial},
author = {Gorman, E. and Rynne, J. and Gardiner, H. and Rostron, A. and Bannard-Smith, J. and Bentley, A. and Brealey, D. and Campbell, C. and Curley, G. and Clarke, M. and Dushianthan, A. and Hopkins, P. and Jackson, C. and Kefala, K. and Krasnodembskaya, A. and Laffey, J. and McDowell, C. and McFarland, M. and McFerran, J. and McGuigan, P. and Perkins, G. and Silversides, J. and Smythe, J. and Thompson, J. and Tunnicliffe, W. and Welters, I. and Amado-Rodríguez, L. and Albaiceta, G. and Williams, B. and Shankar-Hari, M. and O'Kane, C. and McAuley, D.},
month = {jun},
year = {2023},
abstract = {RATIONALE: Mesenchymal stromal cells (MSCs) may modulate inflammation, promoting repair in COVID-19-related Acute Respiratory Distress Syndrome (ARDS).},
volume = {21},
journal = {American Journal of Respiratory and Critical Care Medicine },
publisher = {Springer Nature},
url = {https://doi.org/10.1186/s13063-020-04416-w},
}
